PMID- 15894585 OWN - NLM STAT- MEDLINE DCOM- 20051006 LR - 20220321 IS - 0741-5400 (Print) IS - 0741-5400 (Linking) VI - 78 IP - 2 DP - 2005 Aug TI - Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. PG - 533-43 AB - Ganoderma lucidum, a fungus native to China, has been widely used to promote health and longevity in the Chinese. The polysaccharide component with a branched (1-->6)-beta-D-glucan moiety of G. lucidum (PS-G) has been reported to exert anti-tumor activity and activation of natural killer cells. In this study, we investigated the effects of PS-G on human monocyte-derived dendritic cells (DC). Treatment of DC with PS-G resulted in the enhanced cell-surface expression of CD80, CD86, CD83, CD40, CD54, and human leukocyte antigen (HLA)-DR, as well as the enhanced production of interleukin (IL)-12p70, p40, and IL-10 and also IL-12p35, p40, and IL-10 mRNA expression, and the capacity for endocytosis was suppressed in DC. In addition, treatment of DC with PS-G resulted in enhanced T cell-stimulatory capacity and increased T cell secretion of interferon-gamma and IL-10. Neutralization with antibodies against Toll-like receptor (TLR)-4 inhibited the PS-G-induced production of IL-12 p40 and IL-10, suggesting a vital role for TLR-4 in signaling DC upon incubation with PS-G. Further study showed that PS-G was able to augment inhibitor of kappaB (IkappaB) kinase and nuclear factor (NF)-kappaB activity and also IkappaB alpha and p38 mitogen-activated protein kinase (MAPK) phosphorylation. Further, inhibition of NF-kappaB by helenalin and p38 MAPK by SB98059 prevented the effects of PS-G in the expression of CD80, CD86, CD83, CD40, CD54, and HLA-DR and production of IL-12p70, p40, and IL-10 in various degrees. Taken together, our data demonstrate that PS-G can effectively promote the activation and maturation of immature DC, suggesting that PS-G may possess a potential in regulating immune responses. FAU - Lin, Yu-Li AU - Lin YL AD - Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC. FAU - Liang, Yu-Chih AU - Liang YC FAU - Lee, Shiuh-Sheng AU - Lee SS FAU - Chiang, Bor-Luen AU - Chiang BL LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20050513 PL - England TA - J Leukoc Biol JT - Journal of leukocyte biology JID - 8405628 RN - 0 (Antibodies, Monoclonal) RN - 0 (Antigens, CD) RN - 0 (HLA-DR Antigens) RN - 0 (I-kappa B Proteins) RN - 0 (Interleukins) RN - 0 (Membrane Glycoproteins) RN - 0 (NF-kappa B) RN - 0 (NFKBIA protein, human) RN - 0 (Polysaccharides) RN - 0 (Receptors, Cell Surface) RN - 0 (TLR4 protein, human) RN - 0 (Toll-Like Receptor 4) RN - 0 (Toll-Like Receptors) RN - 139874-52-5 (NF-KappaB Inhibitor alpha) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - Antibodies, Monoclonal/pharmacology MH - Antigens, CD/biosynthesis MH - Cell Differentiation/*drug effects/physiology MH - Cells, Cultured MH - Dendritic Cells/cytology/*physiology MH - HLA-DR Antigens/biosynthesis MH - Humans MH - I-kappa B Proteins/metabolism MH - Interleukins/biosynthesis MH - MAP Kinase Signaling System/*drug effects/physiology MH - Membrane Glycoproteins/antagonists & inhibitors MH - Monocytes/cytology/physiology MH - NF-KappaB Inhibitor alpha MH - NF-kappa B/metabolism MH - Polysaccharides/chemistry/*isolation & purification/*pharmacology MH - Receptors, Cell Surface/antagonists & inhibitors MH - Reishi/*chemistry MH - Toll-Like Receptor 4 MH - Toll-Like Receptors MH - p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism EDAT- 2005/05/17 09:00 MHDA- 2005/10/07 09:00 CRDT- 2005/05/17 09:00 PHST- 2005/05/17 09:00 [pubmed] PHST- 2005/10/07 09:00 [medline] PHST- 2005/05/17 09:00 [entrez] AID - jlb.0804481 [pii] AID - 10.1189/jlb.0804481 [doi] PST - ppublish SO - J Leukoc Biol. 2005 Aug;78(2):533-43. doi: 10.1189/jlb.0804481. Epub 2005 May 13.